{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:18:40Z","timestamp":1790842720181,"version":"4.1.0"},"reference-count":45,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,6,12]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>N-RasG12D and haploinsufficient Tet2 collaborate to induce lethal and highly penetrant CMML in mice with shortened overall survival. N-RasG12D and haploinsufficient Tet2 together promote balanced proliferation and enhanced competitiveness and self-renewal in HSPCs.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018017400","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T15:55:20Z","timestamp":1528127720000},"page":"1259-1271","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":21,"title":["Oncogenic N-Ras and Tet2 haploinsufficiency collaborate to dysregulate hematopoietic stem and progenitor cells"],"prefix":"10.1182","volume":"2","author":[{"given":"Xi","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael","family":"Bailey","sequence":"additional","affiliation":[{"name":"Division of Hematopathology, Department of Pathology, University of Pittsburgh, Pittsburgh, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyasu","family":"Higashimoto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Coolon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Ney","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Michigan, Ann Arbor, MI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Figueroa","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, University of Miami, Miami, FL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and"},{"name":"Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,6,4]]},"reference":[{"issue":"2","key":"2019111618024834300_B1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/onc.2012.48","article-title":"Clonal evolution of acute leukemia genomes","volume":"32","author":"Jan","year":"2013","journal-title":"Oncogene"},{"issue":"3","key":"2019111618024834300_B2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","article-title":"Evolution of the cancer stem cell model","volume":"14","author":"Kreso","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"5","key":"2019111618024834300_B3","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4161\/cc.7.5.5549","article-title":"Leukemia and hematopoietic stem cells: balancing proliferation and quiescence","volume":"7","author":"Jude","year":"2008","journal-title":"Cell Cycle"},{"key":"2019111618024834300_B4","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1038\/bcj.2016.5","article-title":"Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia","volume":"6","author":"Patnaik","year":"2016","journal-title":"Blood Cancer J"},{"issue":"2","key":"2019111618024834300_B5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2012.06.023","article-title":"The origin and evolution of mutations in acute myeloid leukemia","volume":"150","author":"Welch","year":"2012","journal-title":"Cell"},{"issue":"12","key":"2019111618024834300_B6","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/blood-2012-06-440347","article-title":"Clonal architecture of chronic myelomonocytic leukemias","volume":"121","author":"Itzykson","year":"2013","journal-title":"Blood"},{"issue":"24","key":"2019111618024834300_B7","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2009.27.1361","article-title":"Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1","volume":"28","author":"Kohlmann","year":"2010","journal-title":"J Clin Oncol"},{"issue":"12","key":"2019111618024834300_B8","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","article-title":"Prognostic relevance of integrated genetic profiling in acute myeloid leukemia","volume":"366","author":"Patel","year":"2012","journal-title":"N Engl J Med"},{"issue":"9","key":"2019111618024834300_B9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrc3343","article-title":"The role of mutations in epigenetic regulators in myeloid malignancies","volume":"12","author":"Shih","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2019111618024834300_B10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/leu.2013.337","article-title":"The ten-eleven translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases","volume":"28","author":"Solary","year":"2014","journal-title":"Leukemia"},{"issue":"6","key":"2019111618024834300_B11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ajh.24396","article-title":"Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management","volume":"91","author":"Patnaik","year":"2016","journal-title":"Am J Hematol"},{"issue":"1","key":"2019111618024834300_B12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1182\/blood-2009-03-210039","article-title":"Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies","volume":"114","author":"Abdel-Wahab","year":"2009","journal-title":"Blood"},{"issue":"7","key":"2019111618024834300_B13","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/leu.2013.100","article-title":"An evolutionary perspective on chronic myelomonocytic leukemia","volume":"27","author":"Itzykson","year":"2013","journal-title":"Leukemia"},{"issue":"7","key":"2019111618024834300_B14","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.391","article-title":"Acquired mutations in TET2 are common in myelodysplastic syndromes","volume":"41","author":"Langemeijer","year":"2009","journal-title":"Nat Genet"},{"issue":"17","key":"2019111618024834300_B15","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1182\/blood-2010-12-325241","article-title":"Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies","volume":"118","author":"Li","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2019111618024834300_B16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2011.06.001","article-title":"Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation","volume":"20","author":"Moran-Crusio","year":"2011","journal-title":"Cancer Cell"},{"issue":"35","key":"2019111618024834300_B17","doi-asserted-by":"crossref","first-page":"14566","DOI":"10.1073\/pnas.1112317108","article-title":"Ten-eleven-translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice","volume":"108","author":"Ko","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2019111618024834300_B18","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1038\/leu.2012.94","article-title":"TET2 is essential for survival and hematopoietic stem cell homeostasis","volume":"26","author":"Shide","year":"2012","journal-title":"Leukemia"},{"issue":"2","key":"2019111618024834300_B19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1073\/pnas.0307203101","article-title":"Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder","volume":"101","author":"Braun","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"26","key":"2019111618024834300_B20","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1182\/blood-2010-04-281527","article-title":"Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic\/monocytic precursors in a murine model of chronic myelomonocytic leukemia","volume":"116","author":"Wang","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2019111618024834300_B21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood-2010-12-326058","article-title":"Endogenous oncogenic Nras mutation initiates hematopoietic malignancies in a dose- and cell type-dependent manner","volume":"118","author":"Wang","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2019111618024834300_B22","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1182\/blood-2006-09-047530","article-title":"K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem\/progenitor cells","volume":"109","author":"Van Meter","year":"2007","journal-title":"Blood"},{"issue":"6","key":"2019111618024834300_B23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1097","article-title":"RAS oncogenes: the first 30 years","volume":"3","author":"Malumbres","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2019111618024834300_B24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrc2109","article-title":"Hyperactive Ras in developmental disorders and cancer","volume":"7","author":"Schubbert","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2019111618024834300_B25","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood.V99.3.840","article-title":"Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients","volume":"99","author":"Onida","year":"2002","journal-title":"Blood"},{"issue":"19","key":"2019111618024834300_B26","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1200\/JCO.2012.47.3314","article-title":"Prognostic score including gene mutations in chronic myelomonocytic leukemia","volume":"31","author":"Itzykson","year":"2013","journal-title":"J Clin Oncol"},{"issue":"8","key":"2019111618024834300_B27","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1158\/1078-0432.CCR-09-2112","article-title":"RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant","volume":"16","author":"Ricci","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"24","key":"2019111618024834300_B28","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1056\/NEJMoa1208958","article-title":"Progression of RAS-mutant leukemia during RAF inhibitor treatment","volume":"367","author":"Callahan","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111618024834300_B29","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1182\/blood-2010-04-280750","article-title":"Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus","volume":"117","author":"Li","year":"2011","journal-title":"Blood"},{"issue":"7478","key":"2019111618024834300_B30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nature12830","article-title":"Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness","volume":"504","author":"Li","year":"2013","journal-title":"Nature"},{"issue":"1","key":"2019111618024834300_B31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nbt.1517","article-title":"Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells","volume":"27","author":"Foudi","year":"2009","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2019111618024834300_B32","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ccell.2015.03.009","article-title":"Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia","volume":"27","author":"Shih","year":"2015","journal-title":"Cancer Cell"},{"issue":"3","key":"2019111618024834300_B33","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.stem.2012.08.006","article-title":"Less is more: unveiling the functional core of hematopoietic stem cells through knockout mice","volume":"11","author":"Rossi","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"6","key":"2019111618024834300_B34","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.cell.2008.10.048","article-title":"Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair","volume":"135","author":"Wilson","year":"2008","journal-title":"Cell"},{"issue":"7159","key":"2019111618024834300_B35","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature06115","article-title":"Haematopoietic stem cells do not asymmetrically segregate chromosomes or retain BrdU","volume":"449","author":"Kiel","year":"2007","journal-title":"Nature"},{"issue":"10","key":"2019111618024834300_B36","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.exphem.2016.06.253","article-title":"Aging of hematopoietic stem cells: DNA damage and mutations?","volume":"44","author":"Moehrle","year":"2016","journal-title":"Exp Hematol"},{"issue":"1","key":"2019111618024834300_B37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.20042541","article-title":"Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis","volume":"202","author":"Kato","year":"2005","journal-title":"J Exp Med"},{"issue":"4","key":"2019111618024834300_B38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood-2017-01-763219","article-title":"Robust patient-derived xenografts of MDS\/MPN overlap syndromes capture the unique characteristics of CMML and JMML","volume":"130","author":"Yoshimi","year":"2017","journal-title":"Blood"},{"issue":"5","key":"2019111618024834300_B39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ajh.23962","article-title":"Blast transformation in chronic myelomonocytic leukemia: risk factors, genetic features, survival, and treatment outcome","volume":"90","author":"Patnaik","year":"2015","journal-title":"Am J Hematol"},{"issue":"3","key":"2019111618024834300_B40","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/bjh.12871","article-title":"Evaluation of allelic strength of human TET2 mutations and cooperation between Tet2 knockdown and oncogenic Nras mutation","volume":"166","author":"Chang","year":"2014","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111618024834300_B41","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ccr.2010.12.012","article-title":"Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia","volume":"19","author":"Goardon","year":"2011","journal-title":"Cancer Cell"},{"issue":"5","key":"2019111618024834300_B42","doi-asserted-by":"crossref","first-page":"e96209","DOI":"10.1371\/journal.pone.0096209","article-title":"Loss of function of TET2 cooperates with constitutively active KIT in murine and human models of mastocytosis","volume":"9","author":"De Vita","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"2019111618024834300_B43","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/blood-2014-04-567024","article-title":"Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasms","volume":"125","author":"Chen","year":"2015","journal-title":"Blood"},{"issue":"10","key":"2019111618024834300_B44","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1182\/blood-2003-09-3126","article-title":"Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3","volume":"103","author":"Peltola","year":"2004","journal-title":"Blood"},{"issue":"9","key":"2019111618024834300_B45","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ng.3610","article-title":"DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells","volume":"48","author":"Zhang","year":"2016","journal-title":"Nat Genet"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/11\/1259\/882047\/advances017400.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/11\/1259\/882047\/advances017400.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T23:03:07Z","timestamp":1573945387000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/11\/1259\/16079\/Oncogenic-NRas-and-Tet2-haploinsufficiency"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,4]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,6,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018017400","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,4]]}}}